gastric cancer
Showing NaN - NaN of 57
Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)
Active, not recruiting
- Metastatic Cancer
- +4 more
- VE800
- +2 more
-
Scottsdale, Arizona
- +17 more
Jun 22, 2021
Gastric Cancer Trial in Canada, United States (S-1/Cisplatin, 5-FU/cisplatin)
Completed
- Gastric Cancer
-
Huntsville, Alabama
- +32 more
Aug 4, 2020
Esophageal Cancer, Gastric Cancer Trial in United States (everolimus, laboratory biomarker analysis)
Completed
- Esophageal Cancer
- Gastric Cancer
- everolimus
- laboratory biomarker analysis
-
Alhambra, California
- +17 more
Aug 3, 2020
Esophageal Cancer, Gastric Cancer Trial in United States (irinotecan HCl)
Completed
- Esophageal Cancer
- Gastric Cancer
- irinotecan hydrochloride
-
Bakersfield, California
- +24 more
Jul 30, 2020
Esophageal Cancer, Gastric Cancer Trial in Los Angeles, Chicago, Portland (irinotecan HCl, paclitaxel)
Completed
- Esophageal Cancer
- Gastric Cancer
- irinotecan hydrochloride
- paclitaxel
-
Los Angeles, California
- +3 more
Jul 30, 2020
Esophageal Cancer, Gastric Cancer Trial in Los Angeles (G17DT Immunogen, cisplatin, fluorouracil)
Completed
- Esophageal Cancer
- Gastric Cancer
- G17DT Immunogen
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Gastric Cancer, Cancer of the Stomach, Stomach Cancer Trial in Worldwide (Relatlimab + Nivolumab, Nivolumab, Paclitaxel)
Withdrawn
- Gastric Cancer
- +3 more
- Relatlimab + Nivolumab
- +3 more
-
Daphne, Alabama
- +83 more
May 17, 2020
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United States (FOLFOX regimen,
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FOLFOX regimen
- +5 more
-
Mobile, Alabama
- +507 more
Oct 25, 2019
Gastric Cancer Trial in Worldwide (Ramucirumab (IMC-1211B) DP, Placebo, Paclitaxel)
Completed
- Gastric Cancer
- Ramucirumab (IMC-1211B) DP
- +2 more
-
Burbank, California
- +166 more
Sep 6, 2019
Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer Trial in United States (procedure, drug,
Terminated
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FDG-PET
- +7 more
-
Los Angeles, California
- +70 more
Sep 10, 2019
Gastric Cancer, Esophageal Cancer Trial in Los Angeles (oxaliplatin, capecitabine)
Unknown status
- Gastric Cancer
- Esophageal Cancer
- oxaliplatin, capecitabine
-
Los Angeles, CaliforniaU.S.C./Norris Comprehensive Cancer Center
May 14, 2019
Colorectal Cancer (CRC), Gastric Cancer Trial in United States (SC-007)
Terminated
- Colorectal Cancer (CRC)
- Gastric Cancer
-
Los Angeles, California
- +6 more
Apr 25, 2018
Gastric Cancer, Esophageal Tumors Trial in Los Angeles (irinotecan, docetaxel)
Completed
- Gastric Cancer
- Esophageal Neoplasms
- irinotecan, docetaxel
-
Los Angeles, CaliforniaUniversity of Southern California (U.S.C.)/ Norris Comprehensive
Jan 21, 2018
Gastric Cancer, Gastric Adenocarcinoma, Esophageal Cancer Trial in Los Angeles, New York (Irinotecan, Cisplatin, Surgery)
Gastric Cancer Trial in Worldwide (Capecitabine, Cisplatin, Herceptin)
Head Neck Cancer, Liver Cancer, Breast Cancer Trial in United States (CUDC-101)
Completed
- Head and Neck Cancer
- +4 more
-
Encinitas, California
- +6 more
Feb 1, 2016
Pancreatic Cancer, Gastric Cancer, Duodenum Cancer Trial in Los Angeles (irinotecan, radiation therapy)
Completed
- Pancreatic Cancer
- +3 more
- irinotecan
- radiation therapy
-
Los Angeles, CaliforniaU.S.C./Norris Cancer Center
May 20, 2014
Adenocarcinoma, Gastric Cancer Trial in Los Angeles (irinotecan)
Completed
- Adenocarcinoma
- Gastric Cancer
-
Los Angeles, CaliforniaU.S.C. / Norris Comprehensive Cancer Center
May 20, 2014
Gastric Adenocarcinoma, Gastric Cancer Trial in Los Angeles (floxuridine, 5-Fluorouracil, leucovorin, External Beam
Completed
- Gastric Adenocarcinoma
- Gastric Cancer
- floxuridine, 5-Fluorouracil, leucovorin
- +2 more
-
Los Angeles, CaliforniaU.S.C. / Norris Comprehensive Cancer Center
May 20, 2014